These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 198660)

  • 41. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
    Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
    Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region.
    Hassan R; Klumb CE; Felisbino FE; Guiretti DM; White LR; Stefanoff CG; Barros MH; Seuánez HN; Zalcberg IR
    Haematologica; 2008 May; 93(5):780-3. PubMed ID: 18367488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fatal primary Epstein-Barr virus infections with or without infectious mononucleosis (author's transl)].
    Sohier R; Lenoir GM; Lamelin JP
    Ann Med Interne (Paris); 1981; 132(1):48-57. PubMed ID: 7013603
    [No Abstract]   [Full Text] [Related]  

  • 44. Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression.
    Purtilo DT; Sakamoto K
    Hum Pathol; 1981 Aug; 12(8):677-9. PubMed ID: 6269987
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; Paquin L; DeFlorio D; Virzi F; Sakhuja R
    Semin Hematol; 1979 Oct; 16(4):309-43. PubMed ID: 388640
    [No Abstract]   [Full Text] [Related]  

  • 46. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [X-chromosome recessive lymphoproliferative disease (XLP): molecular genetic studies].
    Schuster V; Grimm T; Kress W; Seidenspinner S; Belohradsky BH; Müller P; Kreth HW
    Klin Padiatr; 1995; 207(5):271-6. PubMed ID: 7500602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New oncologic associations for the Epstein-Barr virus.
    Gartner JG; Seemayer TA
    Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; Hutt L; Bhawan J; Yang JP; Cassel C; Allegra S; Rosen FS
    Clin Immunol Immunopathol; 1978 Feb; 9(2):147-56. PubMed ID: 201410
    [No Abstract]   [Full Text] [Related]  

  • 51. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome.
    Grierson H; Purtilo DT
    Ann Intern Med; 1987 Apr; 106(4):538-45. PubMed ID: 3030174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
    Purtilo DT
    Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
    [No Abstract]   [Full Text] [Related]  

  • 53. Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease.
    Egeler RM; de Kraker J; Slater R; Purtilo DT
    Cancer; 1992 Aug; 70(3):683-7. PubMed ID: 1623484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).
    Purtilo DT; Cassel CK; Yang JP; Harper R
    Lancet; 1975 Apr; 1(7913):935-40. PubMed ID: 48119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited immunodeficiency.
    Lancet; 1978 Jan; 1(8056):132-3. PubMed ID: 87559
    [No Abstract]   [Full Text] [Related]  

  • 56. Methods of detection of new families with X-linked lymphoproliferative disease.
    Purtilo DT; Grierson HL
    Cancer Genet Cytogenet; 1991 Feb; 51(2):143-53. PubMed ID: 1847089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hematopathology and Pathogenesis of the X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; Yang JP; Allegra S; DeFlorio D; Hutt LM; Soltani M; Soltani M; Vawter G
    Am J Med; 1977 Feb; 62(2):225-33. PubMed ID: 835602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Report on the X-linked lymphoproliferative disease in an Australian family.
    Turner AM; Berdoukas VA; Tobias VH; Ziegler JB; Toogood IR; Mulley JC; Skare J; Purtilo DT
    J Paediatr Child Health; 1992 Apr; 28(2):184-9. PubMed ID: 1562373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.
    Sullivan JL; Byron KS; Brewster FE; Purtilo DT
    Science; 1980 Oct; 210(4469):543-5. PubMed ID: 6158759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant lymphoma in the X-linked lymphoproliferative syndrome.
    Harrington DS; Weisenburger DD; Purtilo DT
    Cancer; 1987 Apr; 59(8):1419-29. PubMed ID: 3815312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.